US Patent Issued to Watchmaker Genomics on Sept. 1 for "Hot-start antibodies for Taq DNA polymerase variant" (South African Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,103, issued on Sept. 1, was assigned to Watchmaker Genomics Inc. (Boulder, Colo.).

"Hot-start antibodies for Taq DNA polymerase variant" was invented by Phillip Venter (Cape Town, South Africa), Bjarne Faurholm (Cape Town, South Africa) and Eric van der Walt (Cape Town, South Africa).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to Taq polymerase binding antibody compositions and methods of use for nucleic acid amplification."

The patent was filed on Aug. 7, 2025, under Application No. 19/294,142.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO...